Published in Medical Letter on the CDC and FDA, August 30th, 2009
"This article discusses recent data on treatment strategies targeting amyloid and tau pathology. Novel therapeutic strategies such...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.